Literature DB >> 22281491

The carboxyl-terminal region of Crtac1B/LOTUS acts as a functional domain in endogenous antagonism to Nogo receptor-1.

Yuji Kurihara1, Yuko Arie, Masumi Iketani, Hiromu Ito, Kuniyuki Nishiyama, Yasufumi Sato, Fumio Nakamura, Nobuhisa Mizuki, Yoshio Goshima, Kohtaro Takei.   

Abstract

Myelin-derived axon growth inhibitors, such as Nogo, bind to Nogo receptor-1 (NgR1) and thereby limit the action of axonal regeneration after injury in the adult central nervous system. Recently, we have found that cartilage acidic protein-1B (Crtac1B)/lateral olfactory tract usher substance (LOTUS) binds to NgR1 and functions as an endogenous NgR1 antagonist. To examine the functional domain of LOTUS in the antagonism to NgR1, analysis using the deletion mutants of LOTUS was performed and revealed that the carboxyl-terminal region (UA/EC domain) of LOTUS bound to NgR1. The UA/EC fragment of LOTUS overexpressed together with NgR1 in COS7 cells abolished the binding of Nogo66 to NgR1. Overexpression of the UA/EC fragment in cultured chick dorsal root ganglion neurons suppressed Nogo66-induced growth cone collapse. These findings suggest that the UA/EC region is a functional domain of LOTUS serving for an antagonistic action to NgR1.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281491     DOI: 10.1016/j.bbrc.2012.01.033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Expression of NgR1-antagonizing proteins decreases with aging and cognitive decline in rat hippocampus.

Authors:  Heather D VanGuilder Starkey; Georgina V Bixler; William E Sonntag; Willard M Freeman
Journal:  Cell Mol Neurobiol       Date:  2013-03-24       Impact factor: 5.046

2.  LOTUS, a potent blocker of Nogo receptor-1 causing inhibition of axonal growth.

Authors:  Yuji Kurihara; Kohtaro Takei
Journal:  Neural Regen Res       Date:  2015-01       Impact factor: 5.135

Review 3.  Axon growth inhibition by RhoA/ROCK in the central nervous system.

Authors:  Yuki Fujita; Toshihide Yamashita
Journal:  Front Neurosci       Date:  2014-10-22       Impact factor: 4.677

4.  Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1.

Authors:  Xianpeng Ge; Susan Y Ritter; Kelly Tsang; Ruirui Shi; Kohtaro Takei; Antonios O Aliprantis
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

5.  Regulation of axonal regeneration by the level of function of the endogenous Nogo receptor antagonist LOTUS.

Authors:  Tomoko Hirokawa; Yixiao Zou; Yuji Kurihara; Zhaoxin Jiang; Yusuke Sakakibara; Hiromu Ito; Kengo Funakoshi; Nobutaka Kawahara; Yoshio Goshima; Stephen M Strittmatter; Kohtaro Takei
Journal:  Sci Rep       Date:  2017-09-21       Impact factor: 4.379

6.  LOTUS Inhibits Neuronal Apoptosis and Promotes Tract Regeneration in Contusive Spinal Cord Injury Model Mice.

Authors:  Shuhei Ito; Narihito Nagoshi; Osahiko Tsuji; Shinsuke Shibata; Munehisa Shinozaki; Soya Kawabata; Kota Kojima; Kaori Yasutake; Tomoko Hirokawa; Morio Matsumoto; Kohtaro Takei; Masaya Nakamura; Hideyuki Okano
Journal:  eNeuro       Date:  2018-12-14

Review 7.  Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?

Authors:  Min Joung Kim; Jung Hee Kang; Paschalis Theotokis; Nikolaos Grigoriadis; Steven Petratos
Journal:  Cells       Date:  2018-12-20       Impact factor: 6.600

8.  Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip?

Authors:  William Rodemer; Gianluca Gallo; Michael E Selzer
Journal:  Front Cell Neurosci       Date:  2020-07-03       Impact factor: 5.505

9.  LOTUS, an endogenous Nogo receptor antagonist, is involved in synapse and memory formation.

Authors:  Ryohei Nishida; Yuki Kawaguchi; Junpei Matsubayashi; Rie Ishikawa; Satoshi Kida; Kohtaro Takei
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

10.  LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.

Authors:  Shuhei Ito; Narihito Nagoshi; Yasuhiro Kamata; Kota Kojima; Satoshi Nori; Morio Matsumoto; Kohtaro Takei; Masaya Nakamura; Hideyuki Okano
Journal:  Stem Cell Reports       Date:  2021-10-14       Impact factor: 7.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.